Velvette International Pharma Products Limited
Velvette International Pharma Products Limited is a Public Non-govt company company incorporated in 1985 and based in Tamil Nadu, India. Velvette International Pharma Products Limited operates in Chemical substances used in the manufacture of anti-biotic, manufacturing (NIC 24231) with authorized capital of ₹7.50 Cr and paid-up capital of ₹4.93 Cr. For 2015-16, the company reported revenue of ₹0 and a net loss of ₹20.97 L. RegisterKaro's Compliance Health Score for the company is 35/100 (grade F), reflecting a weak compliance posture.
Explore the financials, board members, legal insights, and much more in the complete profile of VELVETTE INTERNATIONAL PHARMA PRODUCTS LIMITED.
Quick facts
Directors
LockedDirectors, DINs & appointment history for Velvette International Pharma Products Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
MCA Filings
Locked| Form | FY | Filed | Due | Delay | Status |
|---|---|---|---|---|---|
| AOC-4 | FY2024-25 | 30 Oct 2024 | 30 Oct 2024 | +37d | filed |
| MGT-7 | FY2024-25 | 20 Nov 2024 | 29 Nov 2024 | 0d | filed |
| AOC-4 | FY2023-24 | 30 Oct 2023 | 30 Oct 2023 | 0d | filed |
| MGT-7 | FY2023-24 | 21 Nov 2023 | 29 Nov 2023 | 0d | filed |
| AOC-4 | FY2022-23 | 30 Oct 2022 | 30 Oct 2022 | 0d | filed |
| MGT-7 | FY2022-23 | 20 Nov 2022 | 29 Nov 2022 | 0d | filed |
Full MCA filing history for Velvette International Pharma Products Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Charges
Locked| Charge ID | Holder | Amount | Created | Status |
|---|---|---|---|---|
| 306389515 | ICICI Bank Ltd(Bank) | ₹13.63 Cr | 19 Sep 2019 | Satisfied |
| 882666621 | State Bank of India(Bank) | ₹6.53 Cr | 27 Jan 2023 | Open |
| 565925054 | Kotak Mahindra Bank Ltd(Bank) | ₹19.45 Cr | 12 Mar 2019 | Open |
| 421575991 | ICICI Bank Ltd(Bank) | ₹13.06 Cr | 19 Sep 2019 | Satisfied |
| 588447735 | Axis Bank Ltd(Bank) | ₹6.80 Cr | 27 Jan 2020 | Satisfied |
| 557469022 | Kotak Mahindra Bank Ltd(Bank) | ₹1.89 Cr | 27 Jan 2022 | Open |
Charge IDs, lenders & amounts for Velvette International Pharma Products Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Financial Performance
MCA| FY | Revenue | PAT | Net Worth | Total Assets | Employees |
|---|---|---|---|---|---|
| 2015-16 | — |
Detailed Financials
1 FYs| Line item | 2015-16 |
|---|---|
| Income statement | |
| Revenue from operations | |
| Other income | |
| Total income | |
| Total expenses | |
| Profit before tax | |
| Profit / (Loss) after tax | |
| Balance sheet | |
| Equity / Net worth | |
| Borrowings | |
| Current liabilities | |
| Total liabilities | |
| Current assets | |
| Cash & equivalents | |
| Total assets | |
| Employees | — |
Cash-flow statement renders when the AOC-4 XBRL Cash Flow context is parsed during the extract phase.
Compounded Annual Growth Rate
Locked| Metric | Latest value | 1Y CAGR | 3Y CAGR | 5Y CAGR |
|---|---|---|---|---|
| Revenue | ₹43.52 Cr | -1.0% | +13.4% | +19.2% |
| Profit after Tax | ₹-82.93 L | +15.7% | -5.3% | -0.1% |
| Net Worth | ₹18.85 Cr | +23.7% | +18.5% | +0.4% |
| Employees | 351 | +18.8% | +6.7% | +15.7% |
Audited financials & ratios for Velvette International Pharma Products Limited.
- Financial Summary & Charts
- Income Statement, Balance Sheet, Cashflow
- Profitability, Liquidity & Growth Ratios
- Audited Financial Statement (AOC-4)
Financial Ratios
| FY | Revenue | PAT | PAT margin | Rev growth | ROE | ROA | D/E | Rev/emp |
|---|---|---|---|---|---|---|---|---|
| 2015-16 | — | — | — | -7.34% | — |
Cap Table & Shareholding
Locked| Category | Shareholders | Shares held | % |
|---|---|---|---|
| Promoters | 2 | 2,84,18,212 | 68.64% |
| Institutional Investors | 2 | 48,07,252 | 11.61% |
| Public & Others | 32 | 81,77,036 | 19.75% |
Promoter, institutional & public holding for Velvette International Pharma Products Limited.
- Incorporation Documents
- Change in Directors & Designated Partner
- Board Resolutions
- Financial Statements & Annual Filings
- Charge Documents (Summary)
Peer Benchmark
228 peersTop 5 in Chemical substances used in the manufacture of anti-biotic, manufacturing
by healthView all ›Events & timeline
2External data sources
7 plannedGSTIN Registrations
Per-state GSTINs + GSTR-1/3B filing cadence + turnover bracket. PAN-keyed scrape.
MSME Payment Delays
Half-yearly disclosure of payments delayed beyond 45 days to MSME suppliers.
Related Party Transactions
Counterparty, nature, transaction value. Inter-company loans, sales, royalty.
Credit Ratings
Long-term + short-term ratings, with rationale on rating actions.
Trademarks
Applied, registered, opposed. Class numbers + status.
Patents
Applications and grants. Inventor names + filing dates.
Legal Cases
Ongoing + past litigations the entity is party to.
Each source is wired as a separate ingestion adapter behind the scraper. Live status flips per CIN as records land.